Open Access

Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma

  • Authors:
    • Kang An
    • Yuehan Zhang
    • Yingjiao Liu
    • Shengxi Yan
    • Zhaowei Hou
    • Meng Cao
    • Guangkuo Liu
    • Congcong Dong
    • Juncha Gao
    • Gaifang Liu
  • View Affiliations

  • Published online on: July 7, 2020     https://doi.org/10.3892/or.2020.7675
  • Pages: 1116-1126
  • Copyright: © An et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Current treatments for esophageal squamous cell carcinoma (ESCC) have limited efficacy. Therefore, the development of novel therapeutic targets to effectively manage the disease and boost survival rates is imperative Neferine, a natural product extracted from Nelumbo nucifera (lotus) leaves, has been revealed to inhibit the growth of hepatocarcinoma, breast cancer and lung cancer cells. However, its effect on ESCC is unknown. In the present study, it was revealed that neferine exerted anti‑proliferative effects in ESCC. It was also revealed that it triggered arrest of the G2/M phase and enhanced apoptosis of ESCC cell lines. Moreover, its ability to trigger accumulation of reactive oxygen species (ROS) and activate the c‑Jun N‑terminal kinase (JNK) pathway was demonstrated. Further study revealed how N‑acetyl cysteine (NAC), a ROS inhibitor, attenuated these effects, demonstrating that ROS and JNK inhibitors mediated a marked reversal of neferine‑triggered cell cycle arrest and apoptosis in ESCC cells. Finally, it was revealed that neferine was involved in the inhibition of Nrf2, an antioxidant factor. Collectively, these findings demonstrated the antitumor effect of neferine in ESCC, through the ROS‑mediated JNK pathway and inhibition of Nrf2, indicating its potential as a target for development of novel and effective therapeutic agents against ESCC.
View Figures
View References

Related Articles

Journal Cover

September-2020
Volume 44 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
An K, Zhang Y, Liu Y, Yan S, Hou Z, Cao M, Liu G, Dong C, Gao J, Liu G, Liu G, et al: Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma. Oncol Rep 44: 1116-1126, 2020
APA
An, K., Zhang, Y., Liu, Y., Yan, S., Hou, Z., Cao, M. ... Liu, G. (2020). Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma. Oncology Reports, 44, 1116-1126. https://doi.org/10.3892/or.2020.7675
MLA
An, K., Zhang, Y., Liu, Y., Yan, S., Hou, Z., Cao, M., Liu, G., Dong, C., Gao, J., Liu, G."Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma". Oncology Reports 44.3 (2020): 1116-1126.
Chicago
An, K., Zhang, Y., Liu, Y., Yan, S., Hou, Z., Cao, M., Liu, G., Dong, C., Gao, J., Liu, G."Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma". Oncology Reports 44, no. 3 (2020): 1116-1126. https://doi.org/10.3892/or.2020.7675